Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson buy francisco20

Start price
€175.60
13.07.22 / 50%
Target price
€168.00
13.07.23
Performance (%)
-19.13%
End price
€142.00
13.07.23
Summary
This prediction ended on 13.07.23 with a price of €142.00. The price of Johnson & Johnson has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.13%. Dividends of €4.40 are taken into consideration when calculating the performance. francisco20 has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y
Johnson & Johnson -3.063% -3.063% -8.843%
iShares Core DAX® -1.370% -3.231% 11.661%
iShares Nasdaq 100 0.172% -3.339% 36.491%
iShares Nikkei 225® -0.801% -7.859% 18.597%
iShares S&P 500 -0.369% -2.979% 26.341%

Comments by francisco20 for this prediction

In the thread Johnson & Johnson diskutieren

francisco20 hat das Wertpapier Johnson & Johnson in seinem Wikifolio Wikifolio WF50PLUSCA von francisco20 gekauft.

Prediction Buy
Perf. (%) -19.13%
Target price 168.000
Change
Ends at 13.07.23

Kursziel gesetzt auf 168,0

In the thread Trading Johnson & Johnson
Prediction Buy
Perf. (%) -19.13%
Target price 168.000
Change
Ends at 13.07.23

Die von francisco20 gewählte maximale Laufzeit wurde überschritten